Print Page   |   Contact Us   |   Report Abuse   |   Sign In   |   Register
ASAP Blog
Blog Home All Blogs
Search all posts for:   

 

View all (257) posts »
 

What’s Brewing in the 2016 Biopharma Conference Beaker? | Part 1

Posted By Cynthia B. Hanson, Tuesday, July 19, 2016

In a recent interview, ASAP CEO Mike Leonetti, CSAP, provided a sampling of what’s to come at the 2016 ASAP BioPharma Conference. He offered insights into the changing landscape for partnerships and how alliance managers and others need to adapt, as well as a preview of speakers and cutting edge sessions and workshops.  

Why is this a must-attend conference for alliance managers, CEOs, and others working in the biopharma, healthcare, and life sciences industries? 

Partnership management is changing. If they are performing their jobs the same way they were two years ago, they likely are leaving money on the table or missing great new opportunities. This year’s conference offers programming to learn how to partner in new environments, which includes tech, academic, and healthcare system partnerships. An ongoing message of the conference is to understand that the ecosystem is getting larger, and their enterprise now represents their company, partners, and the entire healthcare system. As alliance managers, we can no longer be comfortable defining our box as an asset partnership and staying there. We will limit our creation of value in our companies unless we harvest the enterprise. 

What’s new at this year’s conference? 

We are going to talk a lot about the changes in partnerships across the industry. We are not only going to talk about biopharma and healthcare, we are going to hear from people on the tech side of ASAP regarding what’s important and best practices when partnering with tech. It will provide key opportunities to learn about tech companies and how they partner. If biopharma and healthcare are going to partner with tech, each of these industries needs to have a clear understanding of the others’ expectations. 

What timely message is Dr. Samuel Nussbaum, strategic consultant at EGB Advisors, Inc., likely to provide during his keynote address? 

The keynote, “Healing the U.S. Health Care System: Collaboration is Essential,” which is scheduled for the afternoon of Wed., Sept. 7, will tie directly into our theme. Sam is going to talk about his background and expertise with the impact of public policy on healthcare systems and healthcare reform. He will talk a lot about how important collaboration is to finding a solution to our system crisis; my guess is he may try to give examples of how manufacturers, payers, policy experts, academics, and anybody else in the healthcare system can collaborate and partner to overcome major obstacles regarding healthcare reform. 

Who will give the plenary address? 

Our plenary will be given by Stéphane Thiroloix, CEO of Mayoly Spindler, on the morning of Thurs., Sept. 8. Mayoly Spindler is an emerging family-owned, independent French company, originally founded by a husband-and-wife team working to provide gastroenterology and dermatology healthcare solutions. Stéphane joined as managing director in 2014, and he has lots of leadership experience from working in multiple biopharma executive roles before joining Mayoly Spindler. He is an advocate who understands what it takes to be successful in a partnership and basically created the partnership management function in his last two roles.  He will share what a CEO’s expectations are for alliance management success. 

To view the program and download brochure information, go to www. asapweb.org/biopharma.

Tags:  alliance management  biopharma  collaborate  Dr. Samuel Nussbaum  ecosystem  healthcare  healthcare reform  Mayoly Spindler  partner  partnership  Partnership management  Partnerships  public policy  Stéphane Thiroloix  tech 

Share |
Permalink | Comments (0)
 
For more information email us at info@strategic-alliances.org or call +1-781-562-1630